With scant data, RFK Jr. credits Trump for higher European drug pricesnews2026-02-09T20:44:29+00:00February 9th, 2026|Endpoints News|
Orphan drug tweak in US spending bill will make life easier for the FDAnews2026-02-06T19:10:15+00:00February 6th, 2026|Endpoints News|
#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trialnews2026-02-05T17:15:12+00:00February 5th, 2026|Endpoints News|
Rare pediatric PRV program reauthorized until 2029 via government funding lawnews2026-02-04T18:27:40+00:00February 4th, 2026|Endpoints News|
FDA seeks withdrawal of Amgen’s Tavneos, but company says it won’t pull drugnews2026-02-04T00:48:19+00:00February 4th, 2026|Endpoints News|
AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelonews2026-02-03T12:03:52+00:00February 3rd, 2026|Endpoints News|
Medtronic Diabetes expands access to comprehensive insulin delivery solutions following Medicare coverage and new FDA clearancesnews2026-02-02T15:19:19+00:00February 2nd, 2026|Medical Device News Magazine|
FDA rejects Aquestive’s allergy drug over packaging issuesnews2026-02-02T15:17:06+00:00February 2nd, 2026|Endpoints News|
FDA opens submissions for PreCheck program to speed up US factory buildsnews2026-02-02T14:46:33+00:00February 2nd, 2026|Endpoints News|
Pharming’s immunodeficiency drug gets CRL for use in younger patientsnews2026-02-02T11:52:52+00:00February 2nd, 2026|Endpoints News|
